Mary Hu

Mary Hu

Company: Shanghai Miracogen

Job title: Chief Executive Officer


Providing a Clinical Update of an EGFR Targeted ADC MRG003 11:45 am

Review the ADC landscape in China Investigate potent anti-tumour activity in preclinical studies Demonstrate manageable safety and promising efficacy in early phase clinical studiesRead more

day: Track C - Day 1 - AM

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.